FDA officials have identified nine more companies allowed to manufacture and export a banned, lethal drug combination linked ...

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

The case emerged following an investigative report by BBC, which uncovered the sale of Aveo-branded combination medicines in ...

Uncertainty over funding for federal safety net programs may lead some state officials to turn to opioid settlement dollars ...

Indivior (INDV) announced that the FDA has approved label changes for Sublocade including a rapid initiation protocol and alternative injection ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

Indivior PLC (Nasdaq/LSE: INDV), a global leader in addiction treatment, today announced that the U.S. Food and Drug Administration (FDA) has approved label changes for SUBLOCADE® including a rapid ...

The Indian government has taken decisive action against Aveo Pharmaceuticals Ltd (Aveo) after a BBC investigation alleged that the company was illegally exporting unapproved opioid combinations to ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

One way to address the opioid crisis is to clear away red tape and make other pain treatments more easily available, Rep. Melanie Stinnett writes.